A WA parliamentary question asks about the standard protocol for monitoring liver and kidney function in public mental health patients prescribed medications with potential liver/kidney damage side effects. The answer confirms that assessment and monitoring are normal clinical practice.

AnsweredQoN 3386Legislative Council
Asked
16 February 2011
Portfolio
Mental Health

QuestionView source ↗

(1) Given that many medications used to treat mental illness warn of potential liver and/or kidney damage as a side effect of usage, is it standard protocol in public mental health in Western Australia to establish baseline liver and kidney function when prescribing medications which warn of that potential side effect?
(2) If no to (1), why not?
(3) If yes to (1), are follow-up liver and kidney function screens performed periodically to monitor liver and/or kidney function?

AnswerView source ↗

Answered
23 March 2011
Responded by
Minister for Mental Health
Response time
35 days
(1 - 3) It is normal clinical practice for a patient's liver or kidney function to be assessed prior to commencing treatment on a medicine with a side effect known to have a higher risk of causing kidney or liver damage. Periodic follow up assessments of kidney and liver functions are undertaken if a patient remains on the medicine.
Notice: This document is created or edited using unregistered or evaluation copy of rtLib valid for testing or development purposes only. To use it for productive or any other purposes please register it. You may purchase the license on
http://www.rtlib.com

Explore WA Government Data

Search the full archive in the free dashboard, or query programmatically via API.

Explore more